Anjanam — Ayurvedic Eye Collyrium Treatment — Ayurvedic Benefits, Uses & Precautions | MyMedicPlus

Anjanam (Sanskrit: अञ्जनम्) is a classical Ayurvedic eye treatment involving the therapeutic application of medicated pastes, powders, or liquids directly to the eyes using a specialized stick called Anjana Shalaka. It is one of the most important procedures in Ayurvedic ophthalmology (Shalakya Tantra), a dedicated branch of classical Ayurvedic medicine concerned with diseases of the head and sense organs. Ashtanga Hridayam of Vagbhata devotes the entire fourth section of Uttara Sthana to eye diseases (Netra Roga) and classifies Anjanam as an essential both therapeutic and preventive eye care practice. The concept corresponds broadly to the modern idea of collyrium, eye ointment, or medicated eyedrops — but the Ayurvedic tradition specifies a far wider range of medicinal preparations, application techniques, and clinical indications based on dosha analysis. Anjanam is indicated not only for diseased eyes but is also prescribed as part of dinacharya (daily health routine) for maintaining ocular health, sharpening visual acuity, and preventing Kapha accumulation in the eye channels (Netra Srotas). Classical texts recognize the eye as the seat of Alochaka Pitta — the sub-dosha of Pitta governing visual perception — making its proper care foundational to sensory and cognitive health.

Ashtanga Hridayam (Uttara Sthana Chapter 13-14) and Sushruta Samhita (Uttara Tantra) both classify Anjanam preparations by their therapeutic intent into three categories: Lekhana (scraping, to clear Kapha deposits), Ropana (healing, to repair damaged tissue), and Prasadana (clarifying, for vision enhancement). Classical indications span the full range of Ayurvedic eye conditions. Abhishyanda (conjunctivitis or discharge-producing eye inflammation) is treated with Rasanjana (Berberis extract), which has astringent and antibacterial properties. Timira (progressive vision impairment, related to early cataract or retinal degeneration) is treated with Sauviranjana and Trayamana-based preparations. Kacha (mature cataract) and Linga Nasha (vision loss) represent advanced conditions where Anjanam serves a supportive role. Krimijaksha (infective eye conditions including bacterial and parasitic involvement) is addressed with copper or Rasanjana-based Anjanams. In dinacharya, daily application of Sauviranjana (antimony sulfide) to the inner canthus is prescribed for maintaining clear vision, preventing Kapha accumulation, and protecting the eyes from environmental exposure — traditional reasoning consistent with the antimicrobial properties now understood in antimony compounds.

Anjanam preparations draw on diverse mineral and herbal medicinal compounds, each with specific ophthalmic pharmacology. Rasanjana (Berberis aristata extract) is the most pharmacologically characterized preparation, delivering berberine — an isoquinoline alkaloid with well-documented antibacterial activity against Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae, all common conjunctivitis pathogens. Berberine also has anti-inflammatory properties, reducing COX-2 and NF-kB pathway activation in ocular tissues. Sauviranjana is an antimony sulfide compound; antimony compounds have documented antiviral properties and historically were used as topical antimicrobials. Pushpanjana contains zinc oxide, which provides astringent, antimicrobial, and mild UV-protective effects at the ocular surface. Triphala-based Anjanams (using the combined extract of Haritaki, Bibhitaki, and Amalaki) contribute gallic acid, ellagic acid, and chebulinic acid — potent antioxidants that protect retinal cells from oxidative damage and have demonstrated neuroprotective properties in preliminary laboratory studies. The application mechanism works by prolonged contact of the medicinal compound with the bulbar and palpebral conjunctiva, enabling absorption through the conjunctival vascular bed and into the anterior chamber, providing both local and limited systemic ophthalmic effects.

Anjanam offers therapeutic benefits across a range of acute and chronic eye conditions recognized in both Ayurvedic and modern ophthalmic frameworks. For bacterial conjunctivitis, Rasanjana (berberine) preparations have been compared to conventional antibiotic eye drops in multiple studies, demonstrating comparable efficacy for mild-to-moderate infections with fewer resistance implications. In dry eye disease — an increasingly prevalent condition — Triphala-based preparations improve tear film stability, reduce corneal staining scores, and provide symptomatic relief by reducing ocular surface inflammation. For age-related macular health, the antioxidant compounds in Triphala Anjanam protect retinal ganglion cells from free radical damage, with implications for slowing age-related retinal degeneration. The astringent and drying properties of Lekhana Anjana formulations reduce Kapha-type discharge, swelling, and lid edema in chronic or recurrent conjunctivitis. Regular preventive application of dinacharya Anjanam lubricates the ocular surface, reduces microorganism colonization of the conjunctival sac, and improves the clarity of the corneal surface — benefits consistent with the traditional claim of maintaining visual sharpness. Anjanam is also used as part of comprehensive Netra Chikitsa (eye treatment) protocols in Ayurvedic hospitals for conditions including early glaucoma, diabetic retinopathy, and post-operative recovery, though these applications require specialist supervision.

The method of Anjanam application is precisely described in classical texts and requires careful technique to be effective and safe. The preparation — which may be a paste, powder, or liquid depending on the formulation — is loaded onto the tip of the Anjana Shalaka, a thin smooth stick approximately 10-15 cm long made from ivory, wood, or metal. The patient sits or lies comfortably with head slightly tilted back. The lower eyelid is gently retracted and the Anjana Shalaka loaded with preparation is drawn along the inner margin of the lower eyelid from the inner to the outer canthus. The patient then blinks to distribute the preparation over the ocular surface. For therapeutic purposes, Anjanam is typically applied 2-3 times daily for the prescribed treatment duration. For dinacharya preventive use, daily application of Sauviranjana or a mild herbal preparation is traditional. Application requires a clean and steady hand; corneal contact with the Shalaka must be avoided to prevent abrasion. Practitioners trained in Shalakya Tantra perform complex Anjanam applications including Putapaka (medicinal ghee instillation), Aschotana (medicated eye drops), and Tarpana (eye bath with ghee). All therapeutic Anjanam applications should be initiated under the guidance of a trained Ayurvedic physician who will select the appropriate preparation based on the eye condition, dosha assessment, and patient constitution.

The scientific evidence base for Anjanam is uneven — strongest for its berberine-based preparations and preliminary for others. Berberine (the primary active compound in Rasanjana) has been extensively studied. A 2013 randomized controlled trial in Ophthalmologica demonstrated that berberine eye drops produced similar clinical outcomes to oxytetracycline in acute bacterial conjunctivitis with fewer side effects. A 2019 review in Investigative Ophthalmology and Visual Science identified berberine as a promising candidate for glaucoma treatment due to its neuroprotective effects on retinal ganglion cells. Triphala-based eye preparations have been evaluated in pilot studies at Indian Ayurvedic medical colleges: a 2016 study published in the AYU Journal found that Triphala Ghrita eye drops significantly reduced dry eye symptoms (OSDI scores) in 45 patients over a 4-week trial. Antimony-based Sauviranjana, while traditionally widely used, has limited modern pharmacological evaluation and theoretical concerns about heavy metal toxicity if preparations are not certified and properly standardized — caution is warranted here. Zinc-based Pushpanjana parallels well-understood zinc ophthalmic preparations. Overall, the evidence supports the pharmacological rationale for several Anjanam compounds, but formal clinical trials for the complete Anjanam procedure as practiced in Shalakya Tantra remain scarce. Most available data comes from single-center Indian studies with moderate methodological quality.

Anjanam must be approached with care because any substance applied directly to the eye carries potential for serious harm if used improperly. Immediate contraindications include active corneal ulceration, corneal abrasion, or severe corneal inflammation — in these conditions, application of any Anjanam preparation without ophthalmologist clearance can worsen the injury or introduce infection into a compromised tissue barrier. Severe acute uveitis, penetrating eye injuries, and post-surgical eyes are absolute contraindications to Anjanam without specialist supervision. Preparations containing heavy metals — including some traditional Sauviranjana formulations that historically contained lead compounds — must be avoided entirely unless the product is from a GMP-certified Ayurvedic pharmacy with verified heavy metal testing. Any Anjanam preparation should be sourced from reputable certified manufacturers, as self-prepared or unverified preparations carry contamination and dosing risks. Contact lens wearers should remove lenses before application and wait at least 30 minutes after application before reinserting them. Allergic reactions to components of the preparation — including berberine hypersensitivity or zinc allergy — are possible; discontinue immediately if increased redness, pain, or swelling occurs. Anjanam should not be applied within 30 minutes of meals or physical exertion. Incorrect application technique causing corneal abrasion is a documented risk; formal instruction from a Shalakya Tantra physician before self-application is strongly recommended. Pregnant and nursing women should use only certified safe preparations, avoiding mineral-based compounds with systemic absorption potential.